Sfoglia per Autore
D898_E901 RET Deletion Is Oncogenic, Responds to Selpercatinib, and Treatment Resistance Can Arise Via RET-Independent Mechanisms
2023 Porcelli, Tommaso; Moccia, Marialuisa; DE STEFANO, MARIA ANGELA; Ambrosio, Raffaele; Capoluongo, Ettore Domenico; Santoro, Massimo; Hadoux, Julien; Schlumberger, Martin; Carlomagno, Francesca; Salvatore, Domenico
NCOA4 links iron bioavailability to DNA metabolism
2022 Federico, Giorgia; Carrillo, Federica; Dapporto, Francesca; Chiariello, Mario; Santoro, Massimo; Bellelli, Roberto; Carlomagno, Francesca
Discovery of N-Trisubstituted Pyrimidine Derivatives as Type I RET and RET Gatekeeper Mutant Inhibitors with a Novel Kinase Binding Pose
2022 Zhang, Lingtian; Moccia, Marialuisa; Briggs, David C; Bharate, Jaideep B; Lakkaniga, Naga Rajiv; Knowles, Phillip; Yan, Wei; Tran, Phuc; Kharbanda, Anupreet; Wang, Xiuqi; Leung, Yuet-Kin; Frett, Brendan; Santoro, Massimo; Mcdonald, Neil Q; Carlomagno, Francesca; Li, Hong-Yu
Discovery of pyrazolo-thieno[3,2-d]pyrimidinylamino-phenyl acetamides as type-II pan-tropomyosin receptor kinase (TRK) inhibitors: Design, synthesis, and biological evaluation
2021 Yan, W.; Zhang, L.; Lv, F.; Moccia, M.; Carlomagno, F.; Landry, C.; Santoro, M.; Gosselet, F.; Frett, B.; Li, H. -Y.
Targeted activity of the small molecule kinase inhibitor Pz-1 towards RET and TRK kinases
2021 Moccia, M.; Yang, D.; Lakkaniga, N. R.; Frett, B.; Mcconnell, N.; Zhang, L.; Brescia, A.; Federico, G.; Zhang, L.; Salerno, P.; Santoro, M.; Li, H. -Y.; Carlomagno, F.
NCOA4-mediated ferritinophagy in macrophages is crucial to sustain erythropoiesis in mice
2021 Nai, A.; Lidonnici, M. R.; Federico, G.; Pettinato, M.; Olivari, V.; Carrillo, F.; Crich, S. G.; Ferrari, G.; Camaschella, C.; Silvestri, L.; Carlomagno, F.
The pyruvate kinase activator mitapivat reduces hemolysis and improves anemia in a β-thalassemia mouse model
2021 Matte, A.; Federti, E.; Kung, C.; Kosinski, P. A.; Narayanaswamy, R.; Russo, R.; Federico, G.; Carlomagno, F.; Desbats, M. A.; Salviati, L.; Leboeuf, C.; Valenti, M. T.; Turrini, F.; Janin, A.; Yu, S.; Beneduce, E.; Ronseaux, S.; Iatcenko, I.; Dang, L.; Ganz, T.; Jung, C. -L.; Iolascon, A.; Brugnara, C.; De Franceschi, L.
Ret gene fusions in malignancies of the thyroid and other tissues
2020 Santoro, M.; Moccia, M.; Federico, G.; Carlomagno, F.
Bioisosteric discovery of npa101.3, a second-generation ret/vegfr2 inhibitor optimized for single-agent polypharmacology
2020 Moccia, M.; Frett, B.; Zhang, L.; Lakkaniga, N. R.; Briggs, D. C.; Chauhan, R.; Brescia, A.; Federico, G.; Yan, W.; Santoro, M.; Mcdonald, N. Q.; Li, H. -Y.; Carlomagno, F.
Insights into Current Tropomyosin Receptor Kinase (TRK) Inhibitors: Development and Clinical Application
2019 Yan, Wei; Lakkaniga, Naga Rajiv; Carlomagno, Francesca; Santoro, Massimo; Mcdonald, Neil Q.; Lv, Fengping; Gunaganti, Naresh; Frett, Brendan; Li, Hong-Yu
Association between DNA methylation profile and malignancy in follicular-patterned thyroid neoplasms
2019 Affinito, Ornella; Salerno, Paolo; D'Alessio, Alfonso Manuel; Cuomo, Mariella; Florio, Ermanno; Carlomagno, Francesca; Proietti, Agnese; Giannini, Riccardo; Basolo, Fulvio; Chiariotti, Lorenzo; Cocozza, Sergio; Santoro, Massimo
Iron and ferritin modulate MHC Class i expression and NK cell recognition
2019 Sottile, R.; Federico, G.; Garofalo, C.; Tallerico, R.; Faniello, M. C.; Quaresima, B.; Cristiani, C. M.; Di Sanzo, M.; Cuda, G.; Ventura, V.; Wagner, A. K.; Contro, G.; Perrotti, N.; Gulletta, E.; Ferrone, S.; Karre, K.; Costanzo, F. S.; Carlomagno, F.; Carbone, E.
Tamoxifen erythroid toxicity revealed by studying the role of nuclear receptor co-activator 4 in erythropoiesis
2019 Nai, A.; Pettinato, M.; Federico, G.; Olivari, V.; Carlomagno, F.; Silvestri, L.
POR Campania FESR SATIN
2018 Russo, Tommaso; Romano, Mf; Ruocco Maria, Rosaria; Santoro, Massimo; Carlomagno, Francesca
Peroxiredoxin-2: A Novel Regulator of Iron Homeostasis in Ineffective Erythropoiesis
2018 Matte, Alessandro; De Falco, Luigia; Federti, Enrica; Cozzi, Anna; Iolascon, Achille; Levi, Sonia; Mohandas, Narla; Zamo, Alberto; Bruno, Mariasole; Lebouef, Christophe; Janin, Anne; Siciliano, Angela; Ganz, Tom; Federico, Giorgia; Carlomagno, Francesca; Mueller, Sebastian; Silva, Ines; Carbone, Carmine; Melisi, Davide; Kim, Dae Won; Choi, Soo Young; De Franceschi, Lucia
Benzimidazole Analogues and related methods
2017 Carlomagno, Francesca
The Macrophage Nuclear Receptor Coactivator 4 Counteracts Iron-Deficiency Anemia
2017 Federico, Giorgia; Carlomagno, Francesca
The molecular basis for RET tyrosine-kinase inhibitors in thyroid cancer
2017 De Falco, Valentina; Carlomagno, Francesca; Li, Hong-yu; Santoro, Massimo
NCOA4 Links Iron Bioavailability to DNA Metabolism
2017 Federico, G; Bellelli, R; Nai, A; Silvestri, L; Camaschella, C; Iolascon, A; Santoro, M; Carlomagno, F
NCOA4 Deficiency Impairs Systemic Iron Homeostasis
2016 Bellelli, Roberto; Federico, Giorgia; Matte', Alessandro; Colecchia, David; Iolascon, Achille; Chiariello, Mario; Santoro, Massimo; De Franceschi, Lucia; Carlomagno, Francesca
Titolo | Tipologia | Data di pubblicazione | Autore(i) | File |
---|---|---|---|---|
D898_E901 RET Deletion Is Oncogenic, Responds to Selpercatinib, and Treatment Resistance Can Arise Via RET-Independent Mechanisms | 1.1 Articolo in rivista | 2023 | Porcelli, Tommaso; Moccia, Marialuisa; DE STEFANO, MARIA ANGELA; Ambrosio, Raffaele; Capoluongo, Ettore Domenico; Santoro, Massimo; Hadoux, Julien; Schlumberger, Martin; Carlomagno, Francesca; Salvatore, Domenico | |
NCOA4 links iron bioavailability to DNA metabolism | 1.1 Articolo in rivista | 2022 | Federico, Giorgia; Carrillo, Federica; Dapporto, Francesca; Chiariello, Mario; Santoro, Massimo; Bellelli, Roberto; Carlomagno, Francesca | |
Discovery of N-Trisubstituted Pyrimidine Derivatives as Type I RET and RET Gatekeeper Mutant Inhibitors with a Novel Kinase Binding Pose | 1.1 Articolo in rivista | 2022 | Zhang, Lingtian; Moccia, Marialuisa; Briggs, David C; Bharate, Jaideep B; Lakkaniga, Naga Rajiv; Knowles, Phillip; Yan, Wei; Tran, Phuc; Kharbanda, Anupreet; Wang, Xiuqi; Leung, Yuet-Kin; Frett, Brendan; Santoro, Massimo; Mcdonald, Neil Q; Carlomagno, Francesca; Li, Hong-Yu | |
Discovery of pyrazolo-thieno[3,2-d]pyrimidinylamino-phenyl acetamides as type-II pan-tropomyosin receptor kinase (TRK) inhibitors: Design, synthesis, and biological evaluation | 1.1 Articolo in rivista | 2021 | Yan, W.; Zhang, L.; Lv, F.; Moccia, M.; Carlomagno, F.; Landry, C.; Santoro, M.; Gosselet, F.; Frett, B.; Li, H. -Y. | |
Targeted activity of the small molecule kinase inhibitor Pz-1 towards RET and TRK kinases | 1.1 Articolo in rivista | 2021 | Moccia, M.; Yang, D.; Lakkaniga, N. R.; Frett, B.; Mcconnell, N.; Zhang, L.; Brescia, A.; Federico, G.; Zhang, L.; Salerno, P.; Santoro, M.; Li, H. -Y.; Carlomagno, F. | |
NCOA4-mediated ferritinophagy in macrophages is crucial to sustain erythropoiesis in mice | 1.1 Articolo in rivista | 2021 | Nai, A.; Lidonnici, M. R.; Federico, G.; Pettinato, M.; Olivari, V.; Carrillo, F.; Crich, S. G.; Ferrari, G.; Camaschella, C.; Silvestri, L.; Carlomagno, F. | |
The pyruvate kinase activator mitapivat reduces hemolysis and improves anemia in a β-thalassemia mouse model | 1.1 Articolo in rivista | 2021 | Matte, A.; Federti, E.; Kung, C.; Kosinski, P. A.; Narayanaswamy, R.; Russo, R.; Federico, G.; Carlomagno, F.; Desbats, M. A.; Salviati, L.; Leboeuf, C.; Valenti, M. T.; Turrini, F.; Janin, A.; Yu, S.; Beneduce, E.; Ronseaux, S.; Iatcenko, I.; Dang, L.; Ganz, T.; Jung, C. -L.; Iolascon, A.; Brugnara, C.; De Franceschi, L. | |
Ret gene fusions in malignancies of the thyroid and other tissues | 1.8 Articolo in rassegna (review) | 2020 | Santoro, M.; Moccia, M.; Federico, G.; Carlomagno, F. | |
Bioisosteric discovery of npa101.3, a second-generation ret/vegfr2 inhibitor optimized for single-agent polypharmacology | 1.1 Articolo in rivista | 2020 | Moccia, M.; Frett, B.; Zhang, L.; Lakkaniga, N. R.; Briggs, D. C.; Chauhan, R.; Brescia, A.; Federico, G.; Yan, W.; Santoro, M.; Mcdonald, N. Q.; Li, H. -Y.; Carlomagno, F. | |
Insights into Current Tropomyosin Receptor Kinase (TRK) Inhibitors: Development and Clinical Application | 1.1 Articolo in rivista | 2019 | Yan, Wei; Lakkaniga, Naga Rajiv; Carlomagno, Francesca; Santoro, Massimo; Mcdonald, Neil Q.; Lv, Fengping; Gunaganti, Naresh; Frett, Brendan; Li, Hong-Yu | |
Association between DNA methylation profile and malignancy in follicular-patterned thyroid neoplasms | 1.1 Articolo in rivista | 2019 | Affinito, Ornella; Salerno, Paolo; D'Alessio, Alfonso Manuel; Cuomo, Mariella; Florio, Ermanno; Carlomagno, Francesca; Proietti, Agnese; Giannini, Riccardo; Basolo, Fulvio; Chiariotti, Lorenzo; Cocozza, Sergio; Santoro, Massimo | |
Iron and ferritin modulate MHC Class i expression and NK cell recognition | 1.1 Articolo in rivista | 2019 | Sottile, R.; Federico, G.; Garofalo, C.; Tallerico, R.; Faniello, M. C.; Quaresima, B.; Cristiani, C. M.; Di Sanzo, M.; Cuda, G.; Ventura, V.; Wagner, A. K.; Contro, G.; Perrotti, N.; Gulletta, E.; Ferrone, S.; Karre, K.; Costanzo, F. S.; Carlomagno, F.; Carbone, E. | |
Tamoxifen erythroid toxicity revealed by studying the role of nuclear receptor co-activator 4 in erythropoiesis | 1.1 Articolo in rivista | 2019 | Nai, A.; Pettinato, M.; Federico, G.; Olivari, V.; Carlomagno, F.; Silvestri, L. | |
POR Campania FESR SATIN | 8.07 Progetti di Ricerca Finanziati | 2018 | Russo, Tommaso; Romano, Mf; Ruocco Maria, Rosaria; Santoro, Massimo; Carlomagno, Francesca | |
Peroxiredoxin-2: A Novel Regulator of Iron Homeostasis in Ineffective Erythropoiesis | 1.1 Articolo in rivista | 2018 | Matte, Alessandro; De Falco, Luigia; Federti, Enrica; Cozzi, Anna; Iolascon, Achille; Levi, Sonia; Mohandas, Narla; Zamo, Alberto; Bruno, Mariasole; Lebouef, Christophe; Janin, Anne; Siciliano, Angela; Ganz, Tom; Federico, Giorgia; Carlomagno, Francesca; Mueller, Sebastian; Silva, Ines; Carbone, Carmine; Melisi, Davide; Kim, Dae Won; Choi, Soo Young; De Franceschi, Lucia | |
Benzimidazole Analogues and related methods | 6.1 Brevetto | 2017 | Carlomagno, Francesca | |
The Macrophage Nuclear Receptor Coactivator 4 Counteracts Iron-Deficiency Anemia | 1.1 Articolo in rivista | 2017 | Federico, Giorgia; Carlomagno, Francesca | |
The molecular basis for RET tyrosine-kinase inhibitors in thyroid cancer | 1.1 Articolo in rivista | 2017 | De Falco, Valentina; Carlomagno, Francesca; Li, Hong-yu; Santoro, Massimo | |
NCOA4 Links Iron Bioavailability to DNA Metabolism | 1.1 Articolo in rivista | 2017 | Federico, G; Bellelli, R; Nai, A; Silvestri, L; Camaschella, C; Iolascon, A; Santoro, M; Carlomagno, F | |
NCOA4 Deficiency Impairs Systemic Iron Homeostasis | 1.1 Articolo in rivista | 2016 | Bellelli, Roberto; Federico, Giorgia; Matte', Alessandro; Colecchia, David; Iolascon, Achille; Chiariello, Mario; Santoro, Massimo; De Franceschi, Lucia; Carlomagno, Francesca |
Legenda icone
- file ad accesso aperto
- file disponibili sulla rete interna
- file disponibili agli utenti autorizzati
- file disponibili solo agli amministratori
- file sotto embargo
- nessun file disponibile